Abacus Planning Group, Inc. Adicet Bio, Inc. Transaction History
Abacus Planning Group, Inc.
- $667 Million
- Q3 2025
A detailed history of Abacus Planning Group, Inc. transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Abacus Planning Group, Inc. holds 36,764 shares of ACET stock, worth $28,675. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,764
Previous 36,764
-0.0%
Holding current value
$28,675
Previous $22,000
31.82%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ACET
# of Institutions
54Shares Held
53.1MCall Options Held
27.2KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA11.4MShares$8.93 Million0.25% of portfolio
-
Tang Capital Management LLC San Diego, CA8.22MShares$6.41 Million0.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$5.88 Million0.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.75MShares$2.93 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$2.55 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $31.2M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...